|
IncrelexDrug - Increlex The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; SUBCUTANEOUS
Active Ingredient(s) -
Mecasermin Recombinant
Strength -
40MG/4ML(10MG/ML)
Applicant -
TERCICA
New Drug Application (NDA) Number -
021839
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 30, 2005
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Tercica Inc
Increlex
Mazanor 2mg Tablet; Oral
Sanorex 1mg Tablet; Oral Sanorex 2mg Tablet; Oral Mebendazole 100mg Tablet, Chewable; Oral Vermox 100mg Tablet, Chewable; Oral Dormate 600mg Tablet; Oral Inversine 2.5mg Tablet; Oral Increlex 40mg/4ml(10mg/ml) Injectable; Subcutaneous Actinex 10% Cream; Topical Mazanor 1mg Tablet; Oral NewDrugInformation |